Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm G.
Nelson MV, Kim A, Williams PM, Roy-Chowdhuri S, Patton DR, Coffey BD, Reid JM, Piao J, Saguilig L, Alonzo TA, Berg SL, Ramirez NC, Jaju A, Fox E, Weigel BJ, Hawkins DS, Mooney MM, Takebe N, Tricoli JV, Janeway KA, Seibel NL, Parsons DW.
Nelson MV, et al. Among authors: kim a.
Oncologist. 2024 Jun 14:oyae119. doi: 10.1093/oncolo/oyae119. Online ahead of print.
Oncologist. 2024.
PMID: 38873934
Free article.